Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Migraine and Cardiovascular Disease: Systematic Review and Meta-Analysis
BMJ 339:b3914, Sch�rks,M.,et al, 2009
Oral Contraceptives and Increased Headache Prevalence, The Head-HUNT Study
Neurol 66:349-353, Aegidius,K.,et al, 2006
History of Migraine and Risk of Cerebral Ischaemia in Young Adults
Lancet 347:1503-1506, Carolei,A.,et al, 1996
Case-Control Study of Migraine and Risk of Ischaemic Stroke in Young Women
BMJ 310:830-833, Tzourio,C.,et al, 1995
Cerebral Infarction in Young People, A Study of 148 Patients with Early Cerebral Angiography
JNNP 54:576-579, Lisovoski,F.&Rousseaux,P., 1991
Estrogens, Progestins, and Headache
Neurol 41:786-793, Silberstein,S.D.&Merriam,G.R., 1991
Relationship of Migraine Headache & Stroke to Oral Contraceptive Use
J Repro Med 31:1082-1088, Benson,M.D.&Rebar,R.W., 1987
Newer Concepts in Management of Migraine Headaches
J Med Soc N J 74:11, Haidri,N.H.,et al, 1977
Oral Contraceptives & Stroke in Young Women-Collaborative Group
JAMA 231:718, , 1975
Nonatherosclerotic Causes of Stroke
Ann Int Med 70:807, Levine,J.,et al, 1969
Nonatherosclerotic Causes of Stroke
Ann Int Med 70:807, Levine,J.,et al, 1969
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Acute Treatment of Migraine in Children and Adolescents
Neurol 93:487-499, Oskoui, M.,et al, 2019
Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Preventive Migraine Drug Approved
JAMA 320:1746, , 2018
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018
Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018
Lasmiditan is an Effective Acute Treatment for Migraine
Neurol 91:e2222-e2232, Kuca, B.,et al, 2018
CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017
Triptans for Symptomatic Treatment of Migraine Headache
BMJ 348:g2285, Pringsheim, T. & Becker, W.J., 2014
Evidence-based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults
Neurol 78:1337-1345, Silberstein,S.D.,et al, 2012
Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010
Acute Treatment and Prevention of Menstrually Related Migraine Headache: Evidence-Based Review
Neurol 70:1555-1563, Pringsheim,T.,et al, 2008
Sumatriptan-Naproxen for Acute Treatment of Migraine, A Randomized Trial
JAMA 297:1443-1454, Brandes,J.L.,et al, 2007
Treatment of Childhood Migraine Attacks With Oral Zomitriptan and Ibuprofen
Neurol 67:497-499, Evers,S.,et al, 2006
A Randomized Trial of Rizatriptan in Migraine Attacks in Children
Neurol 67:1135-1140, Ahonen,K.,et al, 2006
A Trial of Metoclopramide vs Sumatriptan for the Emergency Department Treatment of Migraines
Neurol 64:463-468, Friedman, B.W., et al, 2005
Nasal Sumatriptan is Effective in Treatment of Migraine Attacks in Children, A Randomized Trial
Neurol 62:883-887, Ahonen,K.,et al, 2004
A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine
Neurol 63:261-269,202, Silberstein,S.D.,et al, 2004
Parenteral Metoclopramide for Acute Migraine: Meta-Analysis of Randomised Controlled Trials
BMJ 329:1369-1372, Colman,I.,et al, 2004
Practice Parameter: Pharmacological Treatment of Migraine Headache in Children and Adolescents
Neurol 63:2215-2224, Lewis,D.,et al, 2004
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Almotriptan (AXERT) and Frovatriptan (FROVA) for Migraine
The Medical Letter 44:19-20, , 2002
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Intracranial Hemorrhages Associated with Sumatriptan
Neurol 56:1243-1244, Combremont,P.C. & Marcus,E.M., 2001
What Matters is Not the Differences Between Triptans, but the Differences Between Patients
Arch Neurol 58:1481-1482, Saper,J.R., 2001
Triptans Are All Different
Arch Neurol 58:1479-1480,1482, Rapoport,A.M.&Tepper,S.J., 2001
Oral Triptans (serotonin 5-HT 1B/1D agnosists) in Acute Migraine Treatment: A Meta-analysis of 53 Trials
Lancet 358:1668-1675, Ferrari,M.D.,et al, 2001
Eletriptan in Acute Migraine:A Double-Blind,Placebo-Controlled Comparison to Sumatriptan
Neurol 54:156-163, Goadsby,P.J.,et al, 2000
Triptans and Migraine
Lancet 355:860-861, Bateman,D.N., 2000
A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents
Pediatrics 106:989-997, Winner,P.,et al, 2000
The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Int Med 159:511-513, Liston,H.,et al, 1999
Intranasal Sumatriptan for the Acute Treatment of Migraine in Children
Neurol 52:1507-1510, Ueberall,M.A.&Wenzel,D., 1999
Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999
A Pilot Study of Oral Sumatriptan as Intermittent Prophylaxis of Menstruation-Related Migraine
Neurol 51:307-309, Newman,L.C.,et al, 1998